ArticleBMC biotechnology2025
An engineered hypoxia-response promoter for human umbilical cord-derived mesenchymal stem cell-based therapeutics.
Song Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it